Inferring structural variant cancer cell fraction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cmero, M. | - |
dc.contributor.author | Yuan, K. | - |
dc.contributor.author | Ong, C.S. | - |
dc.contributor.author | Schröder, J. | - |
dc.contributor.author | Adams, D.J. | - |
dc.contributor.author | Anur, P. | - |
dc.contributor.author | Beroukhim, R. | - |
dc.contributor.author | Boutros, P.C. | - |
dc.contributor.author | Bowtell, D.D.L. | - |
dc.contributor.author | Campbell, P.J. | - |
dc.contributor.author | Cao, S. | - |
dc.contributor.author | Christie, E.L. | - |
dc.contributor.author | Cun, Y. | - |
dc.contributor.author | Dawson, K.J. | - |
dc.contributor.author | Demeulemeester, J. | - |
dc.contributor.author | Dentro, S.C. | - |
dc.contributor.author | Deshwar, A.G. | - |
dc.contributor.author | Donmez, N. | - |
dc.contributor.author | Drews, R.M. | - |
dc.contributor.author | Eils, R. | - |
dc.contributor.author | Fan, Y. | - |
dc.contributor.author | Fittall, M.W. | - |
dc.contributor.author | Garsed, D.W. | - |
dc.contributor.author | Gerstung, M. | - |
dc.contributor.author | Getz, G. | - |
dc.contributor.author | Gonzalez, S. | - |
dc.contributor.author | Ha, G. | - |
dc.contributor.author | Haase, K. | - |
dc.contributor.author | Imielinski, M. | - |
dc.contributor.author | Jerman, L. | - |
dc.contributor.author | Ji, Y. | - |
dc.contributor.author | Jolly, C. | - |
dc.contributor.author | Kleinheinz, K. | - |
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Lee-Six, H. | - |
dc.contributor.author | Leshchiner, I. | - |
dc.contributor.author | Livitz, D. | - |
dc.contributor.author | Malikic, S. | - |
dc.contributor.author | Martincorena, I. | - |
dc.contributor.author | Mitchell, T.J. | - |
dc.contributor.author | Morris, Q.D. | - |
dc.contributor.author | Mustonen, V. | - |
dc.contributor.author | Oesper, L. | - |
dc.contributor.author | Peifer, M. | - |
dc.contributor.author | Peto, M. | - |
dc.contributor.author | Raphael, B.J. | - |
dc.contributor.author | Rosebrock, D. | - |
dc.contributor.author | Rubanova, Y. | - |
dc.contributor.author | Sahinalp, S.C. | - |
dc.contributor.author | Salcedo, A. | - |
dc.contributor.author | Schlesner, M. | - |
dc.contributor.author | Schumacher, S.E. | - |
dc.contributor.author | Sengupta, S. | - |
dc.contributor.author | Shi, R. | - |
dc.contributor.author | Shin, S.J. | - |
dc.contributor.author | Spellman, P.T. | - |
dc.contributor.author | Spiro, O. | - |
dc.contributor.author | Stein, L.D. | - |
dc.contributor.author | Tarabichi, M. | - |
dc.contributor.author | Van, Loo P. | - |
dc.contributor.author | Vembu, S. | - |
dc.contributor.author | Vázquez-García, I. | - |
dc.contributor.author | Wang, W. | - |
dc.contributor.author | Wedge, D.C. | - |
dc.contributor.author | Wheeler, D.A. | - |
dc.contributor.author | Wintersinger, J.A. | - |
dc.contributor.author | Yang, T.-P. | - |
dc.contributor.author | Yao, X. | - |
dc.contributor.author | Yu, K. | - |
dc.contributor.author | Zhu, H. | - |
dc.contributor.author | Corcoran, N.M. | - |
dc.contributor.author | Papenfuss, T. | - |
dc.contributor.author | Hovens, C.M. | - |
dc.contributor.author | Markowetz, F. | - |
dc.contributor.author | Macintyre, G. | - |
dc.contributor.author | PCAWG Evolution and Heterogeneity Working Group | - |
dc.contributor.author | PCAWG Consortium | - |
dc.date.accessioned | 2021-08-31T19:23:04Z | - |
dc.date.available | 2021-08-31T19:23:04Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/60757 | - |
dc.description.abstract | We present SVclone, a computational method for inferring the cancer cell fraction of structural variant (SV) breakpoints from whole-genome sequencing data. SVclone accurately determines the variant allele frequencies of both SV breakends, then simultaneously estimates the cancer cell fraction and SV copy number. We assess performance using in silico mixtures of real samples, at known proportions, created from two clonal metastases from the same patient. We find that SVclone’s performance is comparable to single-nucleotide variant-based methods, despite having an order of magnitude fewer data points. As part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) consortium, which aggregated whole-genome sequencing data from 2658 cancers across 38 tumour types, we use SVclone to reveal a subset of liver, ovarian and pancreatic cancers with subclonally enriched copy-number neutral rearrangements that show decreased overall survival. SVclone enables improved characterisation of SV intra-tumour heterogeneity. © 2020, The Author(s). | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Nature Research | - |
dc.subject | cancer | - |
dc.subject | cell | - |
dc.subject | genome | - |
dc.subject | numerical method | - |
dc.subject | performance assessment | - |
dc.subject | ultrastructure | - |
dc.subject | Article | - |
dc.subject | cancer cell fraction | - |
dc.subject | cell fractionation | - |
dc.subject | computer model | - |
dc.subject | copy number variation | - |
dc.subject | gene frequency | - |
dc.subject | gene rearrangement | - |
dc.subject | genetic algorithm | - |
dc.subject | human | - |
dc.subject | liver cancer | - |
dc.subject | molecular cloning | - |
dc.subject | ovary cancer | - |
dc.subject | overall survival | - |
dc.subject | pancreas cancer | - |
dc.subject | single nucleotide polymorphism | - |
dc.subject | SVclone | - |
dc.subject | whole genome sequencing | - |
dc.subject | algorithm | - |
dc.subject | biology | - |
dc.subject | computer simulation | - |
dc.subject | copy number variation | - |
dc.subject | female | - |
dc.subject | genetics | - |
dc.subject | human genome | - |
dc.subject | liver tumor | - |
dc.subject | male | - |
dc.subject | neoplasm | - |
dc.subject | ovary tumor | - |
dc.subject | pancreas tumor | - |
dc.subject | pathology | - |
dc.subject | procedures | - |
dc.subject | prostate tumor | - |
dc.subject | sensitivity and specificity | - |
dc.subject | Algorithms | - |
dc.subject | Computational Biology | - |
dc.subject | Computer Simulation | - |
dc.subject | DNA Copy Number Variations | - |
dc.subject | Female | - |
dc.subject | Gene Frequency | - |
dc.subject | Genome, Human | - |
dc.subject | Humans | - |
dc.subject | Liver Neoplasms | - |
dc.subject | Male | - |
dc.subject | Neoplasms | - |
dc.subject | Ovarian Neoplasms | - |
dc.subject | Pancreatic Neoplasms | - |
dc.subject | Prostatic Neoplasms | - |
dc.subject | Sensitivity and Specificity | - |
dc.subject | Whole Genome Sequencing | - |
dc.title | Inferring structural variant cancer cell fraction | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, S.J. | - |
dc.identifier.doi | 10.1038/s41467-020-14351-8 | - |
dc.identifier.scopusid | 2-s2.0-85079039901 | - |
dc.identifier.bibliographicCitation | Nature Communications, v.11, no.1 | - |
dc.relation.isPartOf | Nature Communications | - |
dc.citation.title | Nature Communications | - |
dc.citation.volume | 11 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | cancer | - |
dc.subject.keywordPlus | cell | - |
dc.subject.keywordPlus | genome | - |
dc.subject.keywordPlus | numerical method | - |
dc.subject.keywordPlus | performance assessment | - |
dc.subject.keywordPlus | ultrastructure | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | cancer cell fraction | - |
dc.subject.keywordPlus | cell fractionation | - |
dc.subject.keywordPlus | computer model | - |
dc.subject.keywordPlus | copy number variation | - |
dc.subject.keywordPlus | gene frequency | - |
dc.subject.keywordPlus | gene rearrangement | - |
dc.subject.keywordPlus | genetic algorithm | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | liver cancer | - |
dc.subject.keywordPlus | molecular cloning | - |
dc.subject.keywordPlus | ovary cancer | - |
dc.subject.keywordPlus | overall survival | - |
dc.subject.keywordPlus | pancreas cancer | - |
dc.subject.keywordPlus | single nucleotide polymorphism | - |
dc.subject.keywordPlus | SVclone | - |
dc.subject.keywordPlus | whole genome sequencing | - |
dc.subject.keywordPlus | algorithm | - |
dc.subject.keywordPlus | biology | - |
dc.subject.keywordPlus | computer simulation | - |
dc.subject.keywordPlus | copy number variation | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | genetics | - |
dc.subject.keywordPlus | human genome | - |
dc.subject.keywordPlus | liver tumor | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | neoplasm | - |
dc.subject.keywordPlus | ovary tumor | - |
dc.subject.keywordPlus | pancreas tumor | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | procedures | - |
dc.subject.keywordPlus | prostate tumor | - |
dc.subject.keywordPlus | sensitivity and specificity | - |
dc.subject.keywordPlus | Algorithms | - |
dc.subject.keywordPlus | Computational Biology | - |
dc.subject.keywordPlus | Computer Simulation | - |
dc.subject.keywordPlus | DNA Copy Number Variations | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Gene Frequency | - |
dc.subject.keywordPlus | Genome, Human | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Liver Neoplasms | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Neoplasms | - |
dc.subject.keywordPlus | Ovarian Neoplasms | - |
dc.subject.keywordPlus | Pancreatic Neoplasms | - |
dc.subject.keywordPlus | Prostatic Neoplasms | - |
dc.subject.keywordPlus | Sensitivity and Specificity | - |
dc.subject.keywordPlus | Whole Genome Sequencing | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.